For example, in colorectal carcinomas Ras-MAPK pathway alteration are found in the majority of tumors, with a significant pattern of mutual exclusivity of alteration in KRAS, NRAS and BRAF12. This evidence concerns the gene KRAS and colorectal carcinoma.